GlassScriptPhysician profile
Cristobal E Perez
NPI 1184633968
$3,206.65
in general payments reported to CMS, 2019-2025
15 companies · $1,802 in 2025
The $1,802 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $357 · 2022: $418 · 2023: $163 · 2024: $467 · 2025: $1,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,293 · Travel and Lodging: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.34 |
| Travel and Lodging | $1,138.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $1,388.20 | 2025 | Xabo |
| Depuy Synthes Sales INC. | $330.86 | 2022 | |
| Genzyme Corporation | $287.48 | 2022-2025 | |
| Amgen INC. | $214.36 | 2021-2024 | Evenity |
| Medtronic, INC. | $181.11 | 2023-2025 | Mazor X System, Stealthstation S8 Platform, Strata |
| Janssen Pharmaceuticals, INC | $124.99 | 2021 | |
| Alexion Pharmaceuticals, INC. | $120.20 | 2024 | |
| Si-Bone, INC. | $110.55 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $109.89 | 2025 | Dupixent |
| Mirum Pharmaceuticals, INC. | $106.49 | 2025 | Livmarli |
| Acadia Pharmaceuticals INC | $83.32 | 2024 | Daybue |
| Springworks Therapeutics, INC. | $59.06 | 2025 | Gomekli |
| Abbott Laboratories | $45.71 | 2024 | Navitor |
| Stryker Corporation | $23.94 | 2022 | |
| Ucb, INC. | $20.49 | 2025 | Fintepla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristobal Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.